CLARITHROMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Clarithromycin patents expire, and when can generic versions of Clarithromycin launch?
Clarithromycin is a drug marketed by Sandoz, Sun Pharm Inds Ltd, Actavis Labs Fl Inc, Ani Pharms, Dr Reddys Labs Sa, Lupin Ltd, Nostrum Labs Inc, Ranbaxy, Sunshine, Ajanta Pharma Ltd, Alembic, Aurobindo, Chartwell, Hec Pharm, Hikma, Ivax Sub Teva Pharms, Norvium Bioscience, Strides Pharma, Teva, and Wockhardt. and is included in twenty-three NDAs.
The generic ingredient in CLARITHROMYCIN is clarithromycin. There are twenty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clarithromycin
A generic version of CLARITHROMYCIN was approved as clarithromycin by ACTAVIS LABS FL INC on June 24th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLARITHROMYCIN?
- What are the global sales for CLARITHROMYCIN?
- What is Average Wholesale Price for CLARITHROMYCIN?
Summary for CLARITHROMYCIN
See drug prices for CLARITHROMYCIN
Recent Clinical Trials for CLARITHROMYCIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alexandria University | Phase 3 |
| Fu Jen Catholic University Hospital | Phase 4 |
| Fifth Affiliated Hospital, Sun Yat-Sen University | Phase 1 |
Pharmacology for CLARITHROMYCIN
| Drug Class | Macrolide Antimicrobial |
| Mechanism of Action | Cytochrome P450 3A Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for CLARITHROMYCIN
Anatomical Therapeutic Chemical (ATC) Classes for CLARITHROMYCIN
US Patents and Regulatory Information for CLARITHROMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065174-001 | Sep 24, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065144-001 | Oct 18, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Inds Ltd | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065174-002 | Sep 24, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065136-001 | Aug 25, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | CLARITHROMYCIN | clarithromycin | FOR SUSPENSION;ORAL | 065283-002 | Sep 4, 2007 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065384-001 | Aug 20, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ivax Sub Teva Pharms | CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065137-001 | May 31, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
